Patient-reported adverse effects when switching from oral to subcutaneous administration of methotrexate: A prospective, multicenter, paired cohort study.
Overview publication
Title | Patient-reported adverse effects when switching from oral to subcutaneous administration of methotrexate: A prospective, multicenter, paired cohort study. |
Date | 2022-10-01 |
Issue name | Journal of the American Academy of Dermatology |
Issue number | v87.4:920-922 |
DOI | 10.1016/j.jaad.2021.12.039 |
PubMed | 34973976 |
Authors | |
Read | Read publication |